FEROX STRATEGIES

Lobbying for ELI LILLY AND COMPANY · American pharmaceutical company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Pharmacy

Issues related to the pharmaceutical industry. Issues related to treating and reducing obesity. Issues related to drug shortages and counterfeit products.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.